68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.
about
Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic SuccessesCharacterization of 5-(2- 18F-fluoroethoxy)-L-tryptophan for PET imaging of the pancreas.Detection of metastatic insulinoma by positron emission tomography with [(68)ga]exendin-4-a case reportPreclinical evaluation of PAC1 targeting with radiolabeled Maxadilan.A comparison of three (67/68)Ga-labelled exendin-4 derivatives for β-cell imaging on the GLP-1 receptor: the influence of the conjugation site of NODAGA as chelatorRadiolabelled GLP-1 analogues for in vivo targeting of insulinomas.Renal uptake of different radiolabelled peptides is mediated by megalin: SPECT and biodistribution studies in megalin-deficient miceGlucagon-like peptide-1 (GLP-1) analogs: recent advances, new possibilities, and therapeutic implications.PET of insulinoma using ¹⁸F-FBEM-EM3106B, a new GLP-1 analogueCombined Optical Coherence and Fluorescence Microscopy to assess dynamics and specificity of pancreatic beta-cell tracers.Obstacles on the way to the clinical visualisation of beta cells: looking for the Aeneas of molecular imaging to navigate between Scylla and Charybdis.Radioiodinated Exendin-4 Is Superior to the Radiometal-Labelled Glucagon-Like Peptide-1 Receptor Probes Overcoming Their High Kidney Uptake.Evaluation of an [(18)F]AlF-NOTA Analog of Exendin-4 for Imaging of GLP-1 Receptor in InsulinomaGlucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC- 99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma.18F-radiolabeled analogs of exendin-4 for PET imaging of GLP-1 in insulinoma.(111)In-exendin uptake in the pancreas correlates with the β-cell mass and not with the α-cell massEfficient (18)F-Labeling of Synthetic Exendin-4 Analogues for Imaging Beta CellsDevelopment of a new thiol site-specific prosthetic group and its conjugation with [Cys(40)]-exendin-4 for in vivo targeting of insulinomas.Prospective of ⁶⁸Ga-radiopharmaceutical development.Targets and probes for non-invasive imaging of β-cells.Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms.Radiometallated peptides for molecular imaging and targeted therapy.Imaging the islet graft by positron emission tomography.Radiopharmaceutical development of radiolabelled peptides.Radiolabelled peptides for oncological diagnosis.The role of cell lines in the study of neuroendocrine tumors.18F-FDOPA PET/CT imaging of insulinoma revisited.Pancreatic β-cell imaging in humans: fiction or option?Molecular imaging probes derived from natural peptides.In vivo imaging of beta cells with radiotracers: state of the art, prospects and recommendations for development and use.Preliminary evaluation of [18F]AlF-NOTA-MAL-Cys39-exendin-4 in insulinoma with PET.(64)Cu labeled sarcophagine exendin-4 for microPET imaging of glucagon like peptide-1 receptor expression.A standardized method for in vivo mouse pancreas imaging and semiquantitative β cell mass measurement by dual isotope SPECT.Inside the pancreas: progress and challenges of human beta cell mass quantification.F-18 fluorodeoxyglucose positron emission tomography for differential diagnosis of pancreatic tumors.Radiolabeled peptides: valuable tools for the detection and treatment of cancerStriated muscle as implantation site for transplanted pancreatic islets.The effect of purification of Ga-68-labeled exendin on in vivo distribution.Low kidney uptake of GLP-1R-targeting, beta cell-specific PET tracer, 18F-labeled [Nle14,Lys40]exendin-4 analog, shows promise for clinical imaging.Glucagon-like peptide-1 receptor overexpression in cancer and its impact on clinical applications.
P2860
Q28067465-81BC8553-0C84-492F-8BC1-CC2D64565F51Q30828947-1C7AC1DA-22BB-4F92-A101-93C45EFA1633Q33569093-ACBF0F97-D024-4706-AA78-F779BBCB1EE4Q33687453-287FB257-A7D8-4C21-88AA-DDF13A2231EEQ33833281-75CE2053-75F1-4C27-B486-0D512EE514A6Q34579936-AC3934F7-411B-4FD8-BB41-588B3D32AED0Q34647984-BE9C9AF4-DBA4-41F0-A9CD-C99728F7C645Q35087846-2358A3A7-A000-420C-9540-D9823D232EECQ35256800-4AF5F06C-434F-476E-829C-FEDB3C700437Q35623553-AAB5DCCC-BE0B-46DD-B482-9F6469447EC2Q35895009-ACCDFC10-36A5-4D68-A2A7-0FC36F26744DQ36253935-EF7DBCBF-7899-4CCE-9112-B162DE881064Q36383709-8F80F57F-844F-4B4B-9B24-476A61FC40D3Q36662850-66DB9E67-EB15-44A2-AD5F-220B7DF5B22CQ36742916-C05699CE-FF87-45CA-BA55-640276290521Q36926179-FB602050-D0BD-4558-A21F-CBAAABD4F70CQ37134464-120AC880-2E0A-4595-A733-594F1AFD912EQ37188818-F0B4FAB4-3B6B-4E01-A29F-B6F901ECFC69Q37435222-38663B98-998E-4F7A-94C8-B36FC4DF7DC7Q37662672-6B972B9E-78DF-406F-8146-98AEBFDAA88FQ37731335-96A706AC-19FF-4127-AEA9-9AB6E8D12B40Q37847064-C27B224C-89A9-4F08-875C-9CEED6A3B759Q37935646-DCCBEBF7-A3A9-44C5-BC9C-177E4E18E617Q37990399-5628797A-472F-4498-B330-9D7EBB975100Q37990405-6AD8E27A-BD37-4D90-A12D-4F4188CC20D7Q38005913-A7599C0B-96DB-441B-AF8C-43D2C99049BEQ38264851-C9FFE100-88DF-41B1-ADBF-55E0072E3AEDQ38558006-0BB3DA7B-44C0-4475-A7D0-2690F9B592C7Q38748846-C08371E2-0315-46B5-B5CD-6FF356B1755DQ38812324-322658B5-671F-47FB-99B4-831878C0A18DQ38901439-A4EC0261-2B7E-4B90-97CE-DE4F5C6F1C63Q38982109-D1E2578E-6DC4-4D50-BA02-78F4C5F9433EQ39152552-4D076887-1ACD-47C1-82D3-EDED308FF012Q39238015-0D463CE0-13DA-4490-8362-8D180B15F79EQ39467787-239430C3-780C-4029-B05F-F63104753D40Q39596344-26BA4763-679E-4205-A103-60DF76B16B45Q39736837-21E0CDB2-A0FC-4E12-B2E3-9D982EA290FDQ41726979-33517B3D-E944-43E7-AF7F-87E6E900D70CQ41860402-E1F9CDA4-0DB8-4697-87E3-02BA8C403BAAQ42392588-B4D0AA30-46AD-4086-94C3-F6CCF7F44B3C
P2860
68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.
@ast
68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.
@en
type
label
68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.
@ast
68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.
@en
prefLabel
68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.
@ast
68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.
@en
P2093
P2860
P1476
68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.
@en
P2093
Lieke Joosten
Maarten Brom
Martin Gotthardt
Wim J G Oyen
P2860
P2888
P304
P356
10.1007/S00259-009-1363-Y
P577
2010-01-29T00:00:00Z